195 related articles for article (PubMed ID: 23577085)
1. Association between P(16INK4a) promoter methylation and non-small cell lung cancer: a meta-analysis.
Gu J; Wen Y; Zhu S; Hua F; Zhao H; Xu H; You J; Sun L; Wang W; Chen J; Zhou Q
PLoS One; 2013; 8(4):e60107. PubMed ID: 23577085
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of the relationship between RARβ gene promoter methylation and non-small cell lung cancer.
Hua F; Fang N; Li X; Zhu S; Zhang W; Gu J
PLoS One; 2014; 9(5):e96163. PubMed ID: 24796328
[TBL] [Abstract][Full Text] [Related]
3. Does adenomatous polyposis coli gene promoter 1A methylation increase non-small cell lung cancer risk? A meta-analysis.
Hu B; Zhang H; Wei H; Wang Z; Zhang F; Wang X; Li L
Thorac Cancer; 2017 Sep; 8(5):410-416. PubMed ID: 28497891
[TBL] [Abstract][Full Text] [Related]
4. [A meta-analysis of Association between MGMT gene promoter methylation and non-small cell lung cancer].
Fang N; Gu J; Wei H; You J; Zhou Q
Zhongguo Fei Ai Za Zhi; 2014 Aug; 17(8):601-5. PubMed ID: 25130966
[TBL] [Abstract][Full Text] [Related]
5. Bronchial lavage P 16INK4A gene promoter methylation and lung cancer diagnosis: A meta-analysis.
Yifan D; Qun L; Yingshuang H; Xulin L; Jianjun W; Qian M; Yuman Y; Zhaoyang R
Indian J Cancer; 2015 Dec; 52 Suppl 2():e96-8. PubMed ID: 26728683
[TBL] [Abstract][Full Text] [Related]
6. [Meta-analysis of the Association between RASSF1A Gene Promoter Methylation and Non-small Cell Lung Cancer].
Wei H; Fang N; Guo L; Wu Z; Zhou Q
Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):443-50. PubMed ID: 26182870
[TBL] [Abstract][Full Text] [Related]
7. Does hypermethylation of CpG island in the promoter region of the E-cadherin gene increase the risk of lung cancer? A meta-analysis.
Sun Z; Liu G; Xu N
Thorac Cancer; 2019 Jan; 10(1):54-59. PubMed ID: 30390382
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.
Kurakawa E; Shimamoto T; Utsumi K; Hirano T; Kato H; Ohyashiki K
Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839
[TBL] [Abstract][Full Text] [Related]
9. P16
Tuo L; Sha S; Huayu Z; Du K
Thorac Cancer; 2018 Aug; 9(8):1032-1040. PubMed ID: 29927090
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer.
Geng X; Pu W; Tan Y; Lu Z; Wang A; Tan L; Chen S; Guo S; Wang J; Chen X
Oncotarget; 2017 Jan; 8(4):6845-6856. PubMed ID: 28036263
[TBL] [Abstract][Full Text] [Related]
11. Associations between RASSF1A promoter methylation and NSCLC: a meta-analysis of published data.
Liu WJ; Tan XH; Guo BP; Ke Q; Sun J; Cen H
Asian Pac J Cancer Prev; 2013; 14(6):3719-24. PubMed ID: 23886171
[TBL] [Abstract][Full Text] [Related]
12. Association between MGMT promoter methylation and non-small cell lung cancer: a meta-analysis.
Gu C; Lu J; Cui T; Lu C; Shi H; Xu W; Yuan X; Yang X; Huang Y; Lu M
PLoS One; 2013; 8(9):e72633. PubMed ID: 24086261
[TBL] [Abstract][Full Text] [Related]
13. Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis.
Zhang B; Zhu W; Yang P; Liu T; Jiang M; He ZN; Zhang SX; Chen WQ; Chen W
PLoS One; 2011; 6(12):e28882. PubMed ID: 22174919
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of serum p16 gene promoter methylation for diagnosis of nonsmall cell lung cancer.
Yan R; Chi L; Zheng X; Sun R; You J; Ye X
Indian J Cancer; 2015 Dec; 52 Suppl 2():e116-8. PubMed ID: 26728668
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance and a potential drugtarget of RARβ in non-small-cell lung carcinoma: a meta-analysis and a systematic review.
Song X; Shi K; Zhou SJ; Yu DP; Liu Z; Han Y
Drug Des Devel Ther; 2016; 10():1345-54. PubMed ID: 27103788
[TBL] [Abstract][Full Text] [Related]
16. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of DAPK gene promoter hypermethylation in non-small cell lung cancer: A meta-analysis.
Chen Z; Fan Y; Liu X; Shang X; Qi K; Zhang S
Int J Biol Markers; 2022 Mar; 37(1):47-57. PubMed ID: 34935548
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis.
Ota N; Kawakami K; Okuda T; Takehara A; Hiranuma C; Oyama K; Ota Y; Oda M; Watanabe G
Anticancer Res; 2006; 26(5B):3729-32. PubMed ID: 17094392
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the prognostic value of methylation status and expression levels of FHIT, GSTP1 and p16 in non-small cell lung cancer in Egyptian patients.
Haroun RA; Zakhary NI; Mohamed MR; Abdelrahman AM; Kandil EI; Shalaby KA
Asian Pac J Cancer Prev; 2014; 15(10):4281-7. PubMed ID: 24935385
[TBL] [Abstract][Full Text] [Related]
20. Death-associated protein kinase promoter methylation correlates with clinicopathological and prognostic features in nonsmall cell lung cancer patients: A cohort study.
Yang XY; Zhang J; Yu XL; Zheng GF; Zhao F; Jia XJ
J Cancer Res Ther; 2018; 14(Supplement):S65-S71. PubMed ID: 29578152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]